Long-Term Effects With Potential Clinical Importance of Botulinum Toxin Type-A on Mechanics of Muscles Exposed

Autor: Zeynep D. Akdeniz-Doğan, Can A. Yucesoy, Evrim O. Yılmaz, Cemre S. Kaya
Přispěvatelé: Kaya, Cemre S., Yilmaz, Evrim O., Akdeniz-Dogan, Zeynep D., Yucesoy, Can A.
Rok vydání: 2020
Předmět:
collagen
0301 basic medicine
Histology
SYNERGISTIC MUSCLES
NEUROTOXIN TYPE-A
lcsh:Biotechnology
medicine.medical_treatment
MYOFASCIAL FORCE TRANSMISSION
CEREBRAL-PALSY
Biomedical Engineering
LIMB SPASTICITY
Bioengineering
02 engineering and technology
Isometric exercise
DOUBLE-BLIND
03 medical and health sciences
Hydroxyproline
chemistry.chemical_compound
MUSCULAR MECHANICS
lcsh:TP248.13-248.65
MAGNETIC-RESONANCE
medicine
Exertion
Spasticity
Saline
Original Research
active force
Passive resistance
animal model
Compartment (ship)
Bioengineering and Biotechnology
Mechanics
021001 nanoscience & nanotechnology
Botulinum toxin
botulinum toxin type A
muscle mechanical function
passive force
030104 developmental biology
chemistry
ACTIVATED SPASTIC SEMITENDINOSUS
medicine.symptom
MANUAL NEEDLE PLACEMENT
0210 nano-technology
Biotechnology
medicine.drug
Zdroj: Frontiers in Bioengineering and Biotechnology, Vol 8 (2020)
Frontiers in Bioengineering and Biotechnology
ISSN: 2296-4185
DOI: 10.3389/fbioe.2020.00738
Popis: Botulinum toxin type-A (BTX-A) is widely used for spasticity management and mechanically aims at reducing passive resistance at the joint and widening joint range of movement. However, recent experiments on acute BTX-A effects showed that the injected rat tibialis anterior (TA) muscle's passive forces increased, and the length range of active force exertion (l(range)) did not change. Additionally, BTX-A was shown to spread into non-injected muscles in the compartment and affect their mechanics. Whether those effects persist in the long term is highly important, but unknown. The aim was to test the following hypotheses with experiments conducted in the anterior crural compartment of the rat: In the long term, BTX-A (1) maintains l(range), (2) increases passive forces of the injected TA muscle, and (3) spreads into non-injected extensor digitorum longus (EDL) and the extensor hallucis longus (EHL) muscles, also affecting their active and passive forces. Male Wistar rats were divided into two groups: BTX-A and Control (0.1 units of BTX-A or only saline was injected into the TA). Isometric forces of the muscles were measured simultaneously 1-month post-injection. The targeted TA was lengthened, whereas the non-targeted EDL and EHL were kept at constant length. Hydroxyproline analysis was done to quantify changes in the collagen content of studied muscles. Two-way ANOVA test (for muscle forces, factors: TA length and animal group) and unpaired t or Mann-Whitney U test (for l(range) and collagen content, where appropriate) were used for statistical analyses (P < 0.05). BTX-A caused significant effects. TA: active forces decreased (maximally by 75.2% at short and minimally by 48.3%, at long muscle lengths), l(range) decreased (by 22.9%), passive forces increased (by 12.3%), and collagen content increased (approximately threefold). EDL and EHL: active forces decreased (up to 66.8%), passive force increased (minimally by 62.5%), and collagen content increased (approximately twofold). Therefore, hypothesis 1 was rejected and 2 and 3 were confirmed indicating that previously reported acute BTX-A effects persist and advance in the long term. A narrower l(range) and an elevated passive resistance of the targeted muscle are unintended mechanical effects, whereas spread of BTX-A into other compartmental muscles indicates the presence of uncontrolled mechanical effects.
Databáze: OpenAIRE